FDA Approved: TIBSOVO — Original Application (Servier Pharmaceutical LLC)

View source ↗

Summary

FDA approved Tibsovo (ivosidenib) in its original application for the treatment of acute myeloid leukemia, supporting use in patients with IDH1-mutant disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Tibsovo (ivosidenib)

Snippet

ORIG AP for TIBSOVO (IVOSIDENIB)